-
The Medical Letter on Drugs and... Oct 1988
Review
Topics: Cervix Uteri; Contraceptive Devices, Female; Female; Humans; Papanicolaou Test; Vagina; Vaginal Smears
PubMed: 3050407
DOI: No ID Found -
Revue de L'infirmiere Jun 1980
Topics: Contraceptive Devices; Contraceptives, Oral; Female; Humans; Intrauterine Devices; Male
PubMed: 6901227
DOI: No ID Found -
Journal of the American Medical... Nov 1950
Topics: Abdominal Muscles; Contraception; Contraceptive Devices, Female; Diaphragm; Female; Humans
PubMed: 14774241
DOI: No ID Found -
The European Journal of Contraception &... Mar 2007To determine the number of women fitted with a diaphragm or cervical cap at family planning clinics across the Australian State of New South Wales (NSW) from 2000 to... (Comparative Study)
Comparative Study
OBJECTIVES
To determine the number of women fitted with a diaphragm or cervical cap at family planning clinics across the Australian State of New South Wales (NSW) from 2000 to 2005. To compare the demographic characteristics of women fitted with this form of contraceptive with women prescribed the combined oral contraceptive pill (COCP).
METHOD
An audit of women presenting for contraceptive services between 2000 and 2005 was undertaken. The demographic characteristics of women fitted with a barrier method or prescribed the COCP between 1st April, 2002, and 31st October, 2004, were obtained from the Family Planning NSW Activity Data Set (FADS).
RESULTS
The proportion of women fitted with a diaphragm or cap remained constant between 2001 and 2005 at approximately 5%. During the 31 months that the study period lasted, 793 women were fitted with a diaphragm or cervical cap compared with 8047 women prescribed the COCP during the same time frame (including 76 women who received both a diaphragm and COCP prescription during this period). Women fitted with the barrier contraceptive were significantly more likely to be older, to have received a tertiary level education and to have private health insurance than their counterparts prescribed the COCP. They were less likely to come from a non-English speaking background.
DISCUSSION
The diaphragm and cervical cap are viable contraceptive methods for a specific group of older, well-educated women. The possible benefits of female-controlled barrier devices in the prevention of sexually transmissible infections may result in a wider demographic use in the future.
Topics: Adult; Age Factors; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Family Planning Services; Female; Humans; Middle Aged; New South Wales; Socioeconomic Factors
PubMed: 17455041
DOI: 10.1080/13625180601045337 -
Nursing For Women's Health Apr 2019The U.S. Food and Drug Administration approved a new combination hormonal contraceptive in August 2018. Sold under the brand name Annovera, it is a combination of...
The U.S. Food and Drug Administration approved a new combination hormonal contraceptive in August 2018. Sold under the brand name Annovera, it is a combination of segesterone acetate and ethinyl estradiol, and it is the first multiuse vaginal contraceptive system that prevents ovulation for up to 13 menstrual cycles in a year. Although there are several combination hormonal contraceptives on the market, this is the first single system that can be repeatedly used for an entire year and does not require placement by a health care provider. This innovation gives women control over when to stop using the contraceptive, should they so desire. Annovera is stored at room temperature when not in use, allowing women living in uncontrolled-temperature climates to use one contraceptive method for an entire year.
Topics: Contraception; Contraceptive Devices, Female; Drug-Related Side Effects and Adverse Reactions; Ethinyl Estradiol; Humans
PubMed: 30836070
DOI: 10.1016/j.nwh.2019.01.008 -
California Medicine May 1961With the increasing availability of new forms of contraception it is of importance to relate data obtained with new techniques to that obtained with diaphragm and jelly....
With the increasing availability of new forms of contraception it is of importance to relate data obtained with new techniques to that obtained with diaphragm and jelly. This report provides statistical information relative to incidence of pregnancy in a relatively carefully-controlled group of clinic patients. Eighteen pregnancies occurred among 659 patients who used the method for a total of 7,353 cycles.
Topics: Ambulatory Care Facilities; Contraception; Contraceptive Devices, Female; Diaphragm; Female; Humans; Motivation; Pregnancy
PubMed: 13730894
DOI: No ID Found -
AIDS and Behavior Jan 2018This study aimed to assess acceptability and preferences for the SILCS diaphragm for vaginal gel delivery compared to a prefilled applicator. (Randomized Controlled Trial)
Randomized Controlled Trial
INTRODUCTION
This study aimed to assess acceptability and preferences for the SILCS diaphragm for vaginal gel delivery compared to a prefilled applicator.
METHODS
A randomized crossover study among 115 women in South Africa, using both methods during five sex acts.
RESULTS
We found no significant differences in acceptability between the two products. Experience of gel leakage after sex was greater when inserted via applicator. More women were interested in SILCS/gel for multipurpose protection (68%) than in either SILCS alone (17%) or microbicide gel alone (14%).
CONCLUSIONS
A SILCS gel delivery system for multipurpose prevention seems feasible and acceptable.
Topics: Administration, Intravaginal; Adult; Anti-Infective Agents; Coitus; Contraception, Barrier; Contraceptive Devices, Female; Cross-Over Studies; Diaphragm; Drug Delivery Systems; Female; HIV Infections; Humans; Middle Aged; Patient Acceptance of Health Care; South Africa; Treatment Outcome; Vaginal Creams, Foams, and Jellies; Young Adult
PubMed: 28993940
DOI: 10.1007/s10461-017-1913-4 -
Clinical Obstetrics and Gynecology Dec 2007The vaginal contraceptive ring is comprised of ethinyl vinyl acetate that releases ethinyl estradiol and the third-generation progestin, etonorgestrel. It was approved... (Review)
Review
The vaginal contraceptive ring is comprised of ethinyl vinyl acetate that releases ethinyl estradiol and the third-generation progestin, etonorgestrel. It was approved by the Food and Drug Administration in 2001. The vaginal contraceptive ring is highly efficacious with a Pearl Index of 1.18 and an efficacy of 99.1%. Effectiveness is similar with actual use.
Topics: Contraceptive Agents, Female; Contraceptive Devices, Female; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans; Ovulation; Patient Compliance; Patient Satisfaction; Treatment Outcome
PubMed: 17982330
DOI: 10.1097/GRF.0b013e318159c07e -
Contraception Sep 2007We performed a pilot study to evaluate in vivo the fit of the new SILCS diaphragm, a single-size cervical barrier, using magnetic resonance imaging (MRI) in a group of...
BACKGROUND
We performed a pilot study to evaluate in vivo the fit of the new SILCS diaphragm, a single-size cervical barrier, using magnetic resonance imaging (MRI) in a group of women varying in body mass and parity.
STUDY DESIGN
Two healthy premenopausal women were recruited for each of the following groups: body mass index (BMI)<25, BMI=25-30 and BMI>30. One woman in each group was nulliparous and one was multiparous. Subjects were instructed on the placement of the SILCS diaphragm. Each subject underwent three MRI scans: baseline, with the SILCS diaphragm in place and after placement of intravaginal contrast and simulated intercourse.
RESULTS
The SILCS diaphragm was easily identified on MRI. In all subjects, the diaphragm covered the cervix. The position of the diaphragm did not change after simulated intercourse. The appropriate position of the diaphragm, as assessed by the subjects and the practitioner, was corroborated by the MR images. The intravaginal contrast was not readily visible on the images, precluding assessment of the diaphragm's barrier properties.
CONCLUSION
MRI confirms the anatomic position of the SILCS diaphragm in vivo, among a sample of women varying in body mass and parity.
Topics: Administration, Intravaginal; Body Mass Index; Contraceptive Devices, Female; Female; Gadolinium; Genitalia, Female; Humans; Magnetic Resonance Imaging; Parity; Pilot Projects; Pregnancy; Pubic Symphysis
PubMed: 17707723
DOI: 10.1016/j.contraception.2007.05.090 -
Journal of Women's Health (2002) Jul 2010The diaphragm is receiving renewed attention not only for its dual method potential but also because of improved design. To facilitate method re-introduction, we...
BACKGROUND
The diaphragm is receiving renewed attention not only for its dual method potential but also because of improved design. To facilitate method re-introduction, we examined what providers think about this female-controlled barrier contraceptive.
METHODS
A questionnaire administered to 450 women's health nurse practitioners (NPs) asked about their practice experience and issues concerning diaphragm use. Latent class analysis (LCA) was used to identify different groups of providers, based on patterns of perceptions regarding various potential obstacles to diaphragm use. Provider profiles were further described in terms of individual and practice characteristics.
RESULTS
The survey achieved a 47% response rate (n = 214). Respondents saw, on average, 31 family planning patients/week; 87% had fitted a diaphragm, although only 40% had done so in the previous year. Three groups holding significantly different perceptions of obstacles to diaphragm prescription were identified. Group 1 (13% of respondents), with more practice experience in delivering women's healthcare and fitting diaphragms, considered all obstacles relatively inconsequential. Group 2 (40%) had comparatively minor concerns, whereas Group 3 (47%) perceived all issues as major obstacles. All groups stressed the diaphragm's limited promotion, and for 87% of the respondents, concerns about effectiveness and nonfamiliarity with the method also assumed more salience.
CONCLUSIONS
Emerging statistical modeling approaches that go beyond standard aggregate analyses helped identify three groups of women's health nurse practitioners. By considering their diverse perceptions of potential obstacles to diaphragm use, strategies aimed at changing provider behaviors may be developed to reverse declining prescribing rates and retain the diaphragm as a viable reproductive healthcare option for women.
Topics: Adult; Attitude of Health Personnel; Clinical Competence; Contraceptive Devices, Female; Female; Humans; Middle Aged; Models, Statistical; Nurse Practitioners; Practice Patterns, Nurses'; Surveys and Questionnaires
PubMed: 20575680
DOI: 10.1089/jwh.2009.1730